Hutchings, M, Mous, R, Roost Clausen, M, Johnson, P, Linton, K M, Chamuleau, M E D, Lewis, D J, Balari, A S, Cunningham, D, Oliveri, R S, DeMarco, D, Elliott, B, Chen, K & Lugtenburg, P J 2021, ' Subcutaneous (SC) epcoritamab induces complete responses across R/R B-cell NHL subtypes: Updated dose-escalation data ', Annals of Oncology, vol. 32, no. Suppl. 4, pp. S292 . https://doi.org/10.1016/j.annonc.2021.05.546
Clausen, M R, Lugtenburg, P, Hutchings, M, Johnson, P W M, Linton, K M, Lewis, D J, Chamuleau, M, Sureda Balari, A, Cunningham, D, Elliott, B, DeMarco, D, Chen, K & Mous, R 2021, ' Subcutaneous epcoritamab in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Safety profile and antitumor activity : Journal of Clinical Oncology ', Journal of Clinical Oncology, vol. 39, no. Suppl. 15, pp. 7518 . https://doi.org/10.1200/JCO.2021.39.15_suppl.7518